Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
Eur Radiol. 2013 Oct;23(10):2747-53. doi: 10.1007/s00330-013-2883-1. Epub 2013 May 9.
This study aimed to evaluate the safety and efficacy of percutaneous radiological jejunostomy (PRJ) and stent placement in patients with malignant small bowel obstructions (MSBO).
A total of 21 patients (mean age 60 years) with single (n = 4) or multiple (n = 17) MSBO underwent PRJ following jejunopexy. The medical records and imaging studies were retrospectively reviewed to evaluate the technical/clinical success and complications. Clinical success was determined by symptomatic relief and radiologic bowel decompression.
PRJ using a 12- or 14-F drainage catheter was technically successful in all patients. Eleven patients required placement of an 18-F nasogastric tube across one (n = 3), two (n = 6) and three (n = 2) obstructions to achieve clinical success. Subsequently, self-expandable stents were placed through the PRJ tracts to recanalise MSBO in four patients. Clinical success was achieved in 18 patients (85.7 %). The median food intake capacity score improved from 4.0 to 2.0 (P = 0.001). There were one major (peritonitis, 4.8 %) and six minor complications (28.6 %)
PRJ using a nasogastric tube across the obstructions is an effective palliative treatment for MSBO. The PRJ tract can be used as an approach route for stent placement to recanalise MSBO. However, dedicated devices should be developed to reduce frequent procedure-related complications.
• Bowel decompression provides palliative treatment in malignant small bowel obstruction • Percutaneous radiological jejunostomy (PRJ) is a safe and effective palliative treatment. • Long tube placement across obstructions facilitates adequate drainage of multiple bowel obstructions. • PRJ tract can be used for stent placement to approach MSBO recanalisation.
本研究旨在评估经皮放射科空肠造口术(PRJ)和支架置入治疗恶性小肠梗阻(MSBO)的安全性和疗效。
21 例(平均年龄 60 岁)单发(n=4)或多发(n=17)MSBO 患者行空肠固定术后行 PRJ。回顾性分析病历和影像学资料,评估技术/临床成功率和并发症。临床成功通过症状缓解和影像学肠道减压来确定。
所有患者均成功进行了 12 或 14-F 引流导管的 PRJ。11 例患者需要通过一个(n=3)、两个(n=6)和三个(n=2)梗阻放置 18-F 鼻胃管以实现临床成功。随后,通过 PRJ 通道在 4 例患者中放置自膨式支架以再通 MSBO。18 例患者(85.7%)达到临床成功。食物摄入能力评分中位数从 4.0 分提高至 2.0 分(P=0.001)。有 1 例主要并发症(腹膜炎,4.8%)和 6 例次要并发症(28.6%)。
使用鼻胃管穿过梗阻进行 PRJ 是 MSBO 的有效姑息治疗方法。PRJ 通道可用作支架置入以再通 MSBO 的入路。然而,应开发专用设备以减少频繁的与操作相关的并发症。
•肠道减压为恶性小肠梗阻提供姑息性治疗。•经皮放射科空肠造口术(PRJ)是一种安全有效的姑息性治疗方法。•长管穿过梗阻可促进多个肠梗阻的充分引流。•PRJ 通道可用于支架置入以接近 MSBO 再通。